Genesis Healthcare (GEN) Short Interest Ratio & Short Volume

Short interest is the volume of Genesis Healthcare shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 2,300,000 shares of GEN short. 4.13% of Genesis Healthcare's shares are currently sold short. Learn More on Genesis Healthcare's current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Genesis Healthcare: CSS LLC IL, Wolverine Trading LLC, Group One Trading LLC, D. E. Shaw & Co. Inc., Citadel Advisors LLC, Capstone Investment Advisors LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.13% of Genesis Healthcare's floating shares are currently sold short.

Genesis Healthcare saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 2,300,000 shares, an increase of 315.1% from the previous total of 554,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Genesis Healthcare currently has issued a total of 639,130,000 shares. Some of Genesis Healthcare's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Genesis Healthcare currently has a public float of 55,700,000 shares.

4.13% of Genesis Healthcare's shares are currently sold short. Here is how the short interest of companies in the industry of "prepackaged software" compare to Genesis Healthcare: Autodesk, Inc. (1.37%), Snowflake Inc. (3.29%), Atlassian Co. (3.43%), Roblox Co. (2.44%), Cloudflare, Inc. (2.00%), Electronic Arts Inc. (3.17%), Take-Two Interactive Software, Inc. (4.66%), Veeva Systems Inc. (2.68%), Datadog, Inc. (3.40%), HubSpot, Inc. (2.77%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon plc ($5.63 billion), Charter Communications, Inc. ($5.41 billion), Analog Devices, Inc. ($5.32 billion), Baidu, Inc. ($4.45 billion), Snap Inc. ($3.86 billion), Warner Bros. Discovery, Inc. ($3.30 billion), Airbnb, Inc. ($2.82 billion), Bilibili Inc. ($2.34 billion), GameStop Corp. ($2.24 billion), and Expedia Group, Inc. ($2.21 billion). View all of the most shorted stocks.

Short selling GEN is an investing strategy that aims to generate trading profit from Genesis Healthcare as its price is falling. GEN shares are trading up $0.51 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Genesis Healthcare occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GEN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GEN, twice per month. The most recent reporting period available is March, 15 2021.